跳至主要内容
临床试验/NCT04304131
NCT04304131已完成不适用

Colorectal Cancer Screening Using Stool DNA-based SDC2 Methylation Test

Kyung Hee University Hospital at Gangdong11 个研究点 分布在 1 个国家目标入组 1,210 人开始时间: 2020年6月7日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,210
试验地点
11
主要终点
SDC2 methylation in stool DNA

研究概览

简要总结

A study of colorectal cancer screening using stool DNA-based SDC2 methylation test

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Screening
盲法
None

入排标准

年龄范围
12 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient who agreed the clinical trial and signed informed consent
  • High risk patient for colorectal cancer (family history of colorectal cancer, history of adenomatous polyp excision, inflammatory bowel disease > 15 years, or history of hereditary colorectal cancer)
  • Patient who scheduled to receive colonoscopy
  • Stool > 20g before bowel preparation for colonoscopy

排除标准

  • No high risk patient under 60 years
  • History of colorectal cancer
  • Stool < 20g or sample after bowel preparation
  • Diarrhea or liquid stool which cannot be evaluated
  • Patient who is judged as not suitable for clinical trial including a psychiatric disorder by a physician

结局指标

主要结局

SDC2 methylation in stool DNA

时间窗: 1 year

positive ratio of SDC2 methylation

sensitivity and specificity of EarlyTect

时间窗: 1 year

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Suk-Hwan Lee

Professor

Kyung Hee University Hospital at Gangdong

研究点 (11)

Loading locations...

相似试验